NYSE - Delayed Quote USD

Agilent Technologies, Inc. (A)

139.20 +5.29 (+3.95%)
At close: April 23 at 4:00 PM EDT
139.23 +0.03 (+0.02%)
After hours: April 23 at 6:11 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
10/31/2023
10/31/2022
10/31/2021
10/31/2020
Total Revenue
6,735,000.00
6,833,000.00
6,848,000.00
6,319,000.00
5,339,000.00
Cost of Revenue
3,330,000.00
3,368,000.00
3,126,000.00
2,912,000.00
2,502,000.00
Gross Profit
3,405,000.00
3,465,000.00
3,722,000.00
3,407,000.00
2,837,000.00
Operating Expense
2,097,000.00
2,115,000.00
2,104,000.00
2,060,000.00
1,991,000.00
Operating Income
1,308,000.00
1,350,000.00
1,618,000.00
1,347,000.00
846,000.00
Net Non Operating Interest Income Expense
-32,000.00
-44,000.00
-75,000.00
-79,000.00
-70,000.00
Other Income Expense
--
33,000.00
-39,000.00
92,000.00
66,000.00
Pretax Income
1,332,000.00
1,339,000.00
1,504,000.00
1,360,000.00
842,000.00
Tax Provision
96,000.00
99,000.00
250,000.00
150,000.00
123,000.00
Net Income Common Stockholders
1,236,000.00
1,240,000.00
1,254,000.00
1,210,000.00
719,000.00
Diluted NI Available to Com Stockholders
1,236,000.00
1,240,000.00
1,254,000.00
1,210,000.00
719,000.00
Basic EPS
4.22
4.22
4.19
3.98
2.33
Diluted EPS
4.18
4.19
4.18
3.94
2.30
Basic Average Shares
293,250.00
294,000.00
299,000.00
304,000.00
309,000.00
Diluted Average Shares
295,250.00
296,000.00
300,000.00
307,000.00
312,000.00
Total Operating Income as Reported
1,308,000.00
1,350,000.00
1,618,000.00
1,347,000.00
846,000.00
Total Expenses
5,427,000.00
5,483,000.00
5,230,000.00
4,972,000.00
4,493,000.00
Net Income from Continuing & Discontinued Operation
1,236,000.00
1,240,000.00
1,254,000.00
1,210,000.00
719,000.00
Normalized Income
1,236,000.00
1,240,000.00
1,254,000.00
1,210,000.00
719,000.00
Interest Income
60,000.00
51,000.00
9,000.00
2,000.00
8,000.00
Interest Expense
92,000.00
95,000.00
84,000.00
81,000.00
78,000.00
Net Interest Income
-32,000.00
-44,000.00
-75,000.00
-79,000.00
-70,000.00
EBIT
1,424,000.00
1,434,000.00
1,588,000.00
1,441,000.00
920,000.00
EBITDA
1,690,000.00
1,705,000.00
1,905,000.00
1,762,000.00
1,228,000.00
Reconciled Cost of Revenue
3,330,000.00
3,368,000.00
3,126,000.00
2,912,000.00
2,502,000.00
Reconciled Depreciation
266,000.00
271,000.00
317,000.00
321,000.00
308,000.00
Net Income from Continuing Operation Net Minority Interest
1,236,000.00
1,240,000.00
1,254,000.00
1,210,000.00
719,000.00
Normalized EBITDA
1,690,000.00
1,705,000.00
1,905,000.00
1,762,000.00
1,228,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
10/31/2020 - 11/18/1999

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

WAT Waters Corporation
313.30
+4.70%
 
TMO Thermo Fisher Scientific Inc.
574.59
+4.78%
 
DHR Danaher Corporation
253.11
+7.21%
 
IDXX IDEXX Laboratories, Inc.
493.80
+2.97%
 
IQV IQVIA Holdings Inc.
238.62
+3.15%
 
MTD Mettler-Toledo International Inc.
1,241.32
+3.49%
 
ILMN Illumina, Inc.
124.46
+3.50%
 
LH Laboratory Corporation of America Holdings
207.97
+2.41%
 
DGX Quest Diagnostics Incorporated
136.70
+5.08%
 
RVTY Revvity, Inc.
103.50
+2.71%